Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

1H25 Result: Don’t dream it’s over

Lovisa
3:27pm
February 24, 2025
The pace of store rollout has started to accelerate after a period of consolidation, notably in the US over the past two years. We believe Lovisa is poised to hit the landmark of 1,000 stores before the end of the current half, possibly by the time the outgoing CEO Victor Herrero hands over the reins on 31 May. This underscores what we see as the most important element of the Lovisa investment case: the business has a subscale presence in almost every one of the 50 markets in which it operates and significant long-term growth potential in each. We believe the platform for long-term growth is getting stronger all the time. We reiterate our ADD rating. Our target price moves from $36 to $35. LFL sales in 1H25 were less than we had expected at +0.1% (MorgansF: +1.0%) but accelerated to +3.7% in the first 7 weeks of 2H25. This flowed through to 3% lower EBIT than forecast, despite gross margins exceeding our estimate by 90 bps. Lead coverage of Lovisa transfers to Emily Porter with this note.

Trading opportunity emerges with share price fall

Polynovo
3:27pm
February 24, 2025
PNV posted its 1H25 result which was in line with expectations. However, the share price fell sharply (down 8%) which we found surprising and believe has created a buying opportunity. Our forecast growth of 29% for FY25 appears achievable driven by regional expansion and additional indications. We have made no changes to forecasts or TP. Add recommendation maintained.

It’s still tough out there

Reece
3:27pm
February 24, 2025
REH’s 1H25 result was slightly weaker than expected with the housing outlook in both ANZ and the US remaining soft. Key positive: Balance sheet remains healthy with ND/EBITDA (ex-leases) at 0.8x, leaving capacity for ongoing growth investments that will benefit the business over the long term. Key negatives: Volumes and margins were lower in both ANZ and the US; Increased competition has led to market share loss in the US; Cost inflation remains a headwind. We decrease FY25-27F EBITDA by between 2-3%. Our target price falls to $18.70 (from $19.95) and with a 12-month forecast TSR of -1%, we upgrade our rating to Hold (from Reduce). While we continue to see REH as a good business with a strong culture and long track record of growth, the outlook for housing in the near-term remains uncertain despite a likely peak in central bank interest rates in both Australia and the US. REH will also need to respond to aggressive competition in the US, which also adds to the uncertainty on the earnings outlook.

All weather steel cycle performance, with yield

Stanmore Resources
3:27pm
February 24, 2025
Key CY24 financials beat our expectations driven by better realisations/ revenues. The US 6.7c dividend was a positive surprise, helped by a robust balance sheet and a material step down in 2025 capex as internal investment completes. CY25 guidance was materially better than our conservative expectations. SMR trades at ~0.65x P/NPV reflecting depressed investor interest and opacity in the global steel outlook. With a robust balance sheet, and dividends through the cycle, we think SMR offers a compelling option over steel market upside in time for patient investors.

Will organisational reshuffles

Ramsay Health Care
3:27pm
February 24, 2025
Since taking over the reins last Dec, CEO Natalie Davis has started running a ruler over operations, flagging senior leadership changes, updating the operational structure and writing down goodwill related to Elysium mental health business in the UK. Preliminary 1HFY25 results have also been released, which sees underlying operating income decline 1-3% on pcp, and management no longer expecting NPAT growth in FY25. At this early stage, it is difficult to assess if adjustments in operational strategy will have the desired impact, so we continue to remain cautious. We adjust FY25-27 earnings lower, mainly in out years, with our price target decreasing to A$37.74. Hold. CFO Martyn Roberts and Australia CEO Carmel Monaghan will be exiting stage left, with Mr Roberts resigning to “pursue other opportunities” and Ms Monaghan retiring mid-2025. Both will remain with the company during a transition phase. An updated operational structure, which aims to “strengthen the group’s focus on its core Australian hospital business, while building the capabilities necessary to drive transformation and shareholder value”, is slated to be implemented by mid-25 with key changes including: RHC will take a A$291m post-tax goodwill impairment of Elysium, driven by continued occupancy challenges in mental health rehabilitation and neurological services, as well as a slower than planned ramp up in occupancy at new site, partially offset by the increase in valuation for UK Hospitals driven by an improved tariff outlook in 2004/05 and public/private partnership momentum. In an attempt to improve Elysium’s performance, a COO commended in Jan-25, targeting “operational rigour” with a “focus on financial outcomes”. In addition, consultants have been hired to “identify initiatives to improve profitability”. A A$64.5m tax liability provision release for Ramsay Santé will also be taken, as the time period to hold the provision has lapsed.

NEU adds another two zombie designations

Neuren Pharmaceuticals
3:27pm
February 24, 2025
NEU has announced the granting of FDA’s Rare Pediatric Disease Designation (RPD) for both Pitt Hopkins (PH) and Angelman Syndrome (AS), both neurological disorders which emerge in early childhood and currently have no approved treatments. These designations allow companies to apply for various incentives, including the highly-prized Priority Review Voucher (PRV) which awards RPD participants a voucher which can be used to accelerate the FDA’s review process, or can opt to on-sell to another drug developer to use. However, there remains uncertainty under current legislation where the PRV program was active up until September 2024 but has not since been reauthorised. The sunsetting of incentives currently only allows the awarding of the vouchers for approved designations up until late 2026, but seemingly not the qualifying tickets to entry which it continues to award. Given the time it takes to run Ph3 pivotal trials along with the NDA submission process, the designations are effectively zombie designations with no material benefit unless US congress reauthorise the program. A bill introduced in December 2024 (with bipartisan support) which would have extended the sunset date for another 4+ years ran into political challenges and ultimately stripped back many provisions which included the PRV extension. We note that congress has since passed several of the bills originally stripped out of the continuing resolutions, which gives some degree of hope for the program in the near-term. However, from our searches we cannot find any current commentary from the FDA or heard of this program being on the ticket for discussion at the congressional level at this stage.

1H25 earnings: From holding the ball to tightening the reins

Tabcorp Holdings
3:27pm
February 24, 2025
TAH’s 1H25 result was its most encouraging update for some time prompting a positive share price reaction on the day. The appointment of Gill McLachlan as CEO is a key catalyst for driving change, as reflected in his first interim result. Despite softer turnover, total domestic wagering revenue (pre-VRI interest) rose 1%, supported by strong cash performance and resilient digital yields. Encouragingly, FY25 OpEx savings guidance increased from $20m to $30m (MorgansF: $693m) while CapEx and D&A guidance were also revised downwards. Following the result, we have raised our earnings forecasts by 3.2% in FY25 and 1.4% in FY26. Our key takeaway from the investor call is a notable shift in sentiment compared to the previous year. While near-term wagering conditions may appear choppy, we see long-term potential, supported by a series of specialised hires aimed at maximising value from TAH's existing asset base. We upgrade TAH to an Add recommendation and increase our price target to $0.75.

Cooler Runnings

Lindsay Australia
3:27pm
February 23, 2025
LAU’s 1H25 result was much weaker than expected as softer trading conditions and increased competition impacted LAU’s transport segment. Group EBITDA (pre AASB16) of A$47.3m was down -9.2% yoy, -7% lower than MorgF $50.8m. Underlying NPAT also fell -20% yoy to $15.8m also short of MorgF/ Consensus. Management commentary reflects expectations for operating conditions to remain challenging into 2H25. Given this near-term outlook and uncertainty surrounding the recovery in broader conditions we reduce FY25-27F EBITDA by -15%. We move to a Hold rating with a revised target of $0.80ps (from $1.15ps).

1H25 earnings: Upside beyond jackpot cycles

Jumbo Interactive
3:27pm
February 23, 2025
JIN delivered a resilient result despite a weaker jackpotting period in the first half. Looking ahead, JIN will be comping its strongest second half to date, though margins should benefit from effective cost management and incremental upside from Daily Winners. We remain comfortable sitting below consensus for FY26, given uncertainties around draws and recovery in Managed Services. Despite this, we see limited downside (<10x FY25-26F EV/EBITDA), supported by a strong net cash position. We see upside to guided Managed Services margins, driven by contract mix and FX benefits. We maintain our Add recommendation, with our PT reduced to $13.60 (previously $14.60).

Lets taco’bout those comps

Guzman y Gomez
3:27pm
February 23, 2025
Whilst GYG’s 1H25 result didn’t deliver a much anticipated beat and consensus earnings upgrade, it was nonetheless a strong half of execution and growth. Importantly, comp sales growth continues to accelerate into the 2H25 and GYG now expects to exceed its prospectus forecasts (consensus was already above). Following share price weakness, we upgrade to ADD.

News & Insights

On 7 July the AFR published a list of 37 Economists who had answered a poll on when the RBA would next cut rates. 32 of them thought that the RBA would cut on 8 July. Only 5 of them did not believe the RBA would cut, Michael Knox being one of them.

On 7 July the AFR published a list of 37 Economists who had answered a poll on when the RBA would next cut rates. 32 of them thought that the RBA would cut on 8 July. Only 5 of them did not believe the RBA would cut on 8 July. I was one of them. The RBA did not cut.

So today I will talk about how I came to that decision. First, lets look at our model of official interest rates. Back in January 2015 I went to a presentation in San Franciso by Stan Fishcer . Stan was a celebrated economist who at that time was Ben Bernanke's deputy at the Federal Reserve. Stan gave a talk about how the Fed thought about interest rates.

Stan presented a model of R*. This is the real short rate of the Fed Funds Rate at which monetary policy is at equilibrium. Unemployment was shown as a most important variable. So was inflationary expectations.

This then logically lead to a model where the nominal level of the Fed funds rate was driven by Inflation, Inflationary expectations and unemployment. Unemployment was important because of its effect on future inflation. The lower the level of unemployment the higher the level of future inflation and the higher the level of the Fed funds rate. I tried the model and it worked. It worked not just for the Fed funds rate. It also worked in Australia for Australian cash rate.

Recently though I have found that while the model has continued to work to work for the Fed funds rate It has been not quite as good in modelling that Australian Cash Rate. I found the answer to this in a model of Australian inflation published by the RBA. The model showed Australian Inflation was not just caused by low unemployment, It was also caused by high import price rises. Import price inflation was more important in Australia because imports were a higher level of Australian GDP than was the case in the US.

This was important in Australia than in the US because Australian import price inflation was close to zero for the 2 years up to the end of 2024. Import prices rose sharply in the first quarter of 2025. What would happen in the second quarter of 2025 and how would it effect inflation I could not tell. The only thing I could do is wait for the Q2 inflation numbers to come out for Australia.

I thought that for this reason and other reasons the RBA would also wait for the Q2 inflation numbers to come out. There were other reasons as well. The Quarterly CPI was a more reliable measure of the CPI and was a better measure of services inflation than the monthly CPI. The result was that RBA did not move and voiced a preference for quarterly measure of inflation over monthly version.

Lets look again at R* or the real level of the Cash rate for Australia .When we look at the average real Cash rate since January 2000 we find an average number of 0.85%. At an inflation target of 2.5 % this suggests this suggest an equilibrium Cash rate of 3.35%

Model of the Australian Cash Rate


What will happen next? We think that the after the RBA meeting of 11 and 12 August the RBA will cut the Cash rate to 3.6%

We think that after the RBA meeting of 8 and 9 December the RBA will cut the Cash rate to 3.35%

Unless Quarterly inflation falls below 2.5% , the Cash rate will remain at 3.35% .

Read more
Investment Watch is a quarterly publication for insights in equity and economic strategy. Recent months have been marked by sharp swings in market sentiment, driven by shifting global trade dynamics, geopolitical tensions, and policy uncertainty.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy.

This publication covers

Economics - 'The challenge of Australian productivity' and 'Iran, from the Suez blockade to the 12 day war'
Asset Allocation
- 'Prioritise portfolio resilience amidst the prevailing uncertainty'
Equity Strategy
- 'Rethinking sector preferences and portfolio balance'
Fixed Interest
- 'Market volatility analysis: Low beta investment opportunities'
Banks
- 'Outperformance driving the broader market index'
Industrials
- 'New opportunities will arise'
Resources and Energy
- 'Getting paid to wait in the majors'
Technology
- 'Buy the dips'
Consumer discretionary
- 'Support remains in place'
Telco
- 'A cautious eye on competitive intensity'
Travel
- 'Demand trends still solid'
Property
- 'An improving Cycle'

Recent months have been marked by sharp swings in market sentiment, driven by shifting global trade dynamics, geopolitical tensions, and policy uncertainty. The rapid pace of US policy announcements, coupled with reversals, has made it difficult for investors to form strong convictions or accurately assess the impact on growth and earnings. While trade tariffs are still a concern, recent progress in US bilateral negotiations and signs of greater policy stability have reduced immediate headline risks.

We expect that more stable policies, potential tax cuts, and continued innovation - particularly in AI - will support a gradual pickup in investment activity. In this environment, we recommend prioritising portfolio resilience. This means maintaining diversification, focusing on quality, and being prepared to adjust exposures as new risks or opportunities emerge. This quarter, we update our outlook for interest rates and also explore the implications of the conflict in the Middle East on portfolios. As usual, we provide an outlook for the key sectors of the Australian market and where we see the best tactical opportunities.


Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more
From Houthi attacks on Suez Canal shipping to Trump’s Operation Rough Rider and Iran’s nuclear facility strikes, explore how these events shape oil prices.

At the beginning of the week, I was asked to write something about Iran. When I started looking at what had been happening , I realised that what we were talking about begins with an action by a proxy of Iran back in November 2023. How  that was initially handled with the Biden regime, and how then it was dealt with  deftly by Trump this year,   in turn led to  the need for an attack on Iran's nuclear facility.

Winston Churchill noted in his first volume of his history of the Second World War that it was important to understand that the United States is primarily a naval power. Indeed, the US remains the world dominant naval power. As such, two major strategic concerns remain for the US : the control of the Suez Canal and the Panama Canal .

To the US The idea that another country might block access to either of these must be intolerable. Yet what began happening, beginning on the 19th November 2023, was that , Houthi rebels that controlled a the northern part of a small country in southwestern Arabia, began to act. These Houthi rebels were acting as a proxy for Iran. They were funded by Iran, and armed with Ship-killing rockets, by Iran.

By February 2024, they had attacked 40 ships which had been attempting to sail northwards towards the Suez Canal. By March 2024, 200 ships had been diverted away from the Suez Canal and forced to make the longer and more expensive voyage around the Cape of Good Hope of South Africa. At this point, I think The Economist magazine said that this was the most severe Suez crisis since the 1950s.

The U.S. did respond. On the 18th December 2023, the U.S. had announced an international maritime force to break the Houthi blockade. On the 10th January, the UN National Security Council adopted a resolution demanding a cessation of Houthi attacks on merchant vessels.

As of the 2nd January 2024, the Houthis had already recorded 931 American and British airstrikes against sites in Yemen. Then Trump came to power. To Trump, the idea of the proxy of Iran blockading the Suez Canal could not be tolerated.

From the 15th March 2025, Trump began "Operatation  Rough Rider". This was named for the cavalry commanded by the then-future President Theodore Roosevelt, who charged up San Juan Hill in Cuba during the Spanish-American War of 1898. The U.S. then hit the Houthis with over a thousand airstrikes. So they were bombing at ten times the rate they previously had been. The result of that was that by the 6th March 2025, Trump announced that the Houthis, these proxies of Iran, had capitulated as part of a ceasefire brokered by Oman. This directly led to the main game.

It was obvious that the decision to do the unthinkable, and block the Suez Canal, had come from Iran.
What other unthinkable things was Iran considering?

It is obvious that Trump now believed that the next unthinkable thing that Iran was considering was nuclear weapons. As Iran's other proxies collapsed, Iran's air defence collapsed. In turn, this gave Trump the room to act, and he took it. He launched a bombing raid which severely disabled Iran's nuclear capacity. Some say it completely destroyed it.

Iran retaliated by launching 14 rockets at the American base in Qatar, warning the Americans this was going to happen, and this had no other effect than allowing Iran to announce a glorious victory by themselves over the Americans. Iran had thought the unthinkable and had achieved what was, to them, as a result, an unthinkable reverse.

The ceasefire that has followed has been interpreted by markets as a relief from major risk. Now, the major effect of this on markets has been a dramatic rocketing in the oil price, followed by a fall in the oil price. So I thought I’d look at the fundamentals of the oil price, from running two of my models of the Brent price, using current fundamentals.

Now, the simplest model that I’ve got explains 63% of monthly variation of the Brent oil price. And it’s based on two things. One is the level of stocks in the U.S., which are published every week by the Energy Information Administration .  Those stocks are  down a bit in the most recent months because this is the summer driving season where oil stocks are being drawn down to provide higher demand for gasoline. So that’s a positive thing. And the other thing that I’ve been talking about this year is that I think  we’re going to see a steady fall in the U.S. dollar, and that’s going to generate the beginning of a recovery in commodities prices. So if I also put the U.S. dollar index into this model, it gives me an equilibrium model now of $78.96. And that’s about $US12  higher than the oil price was this morning.

If I strengthen that model by adding the U.S. CPI, because, you know, the cost of production cost of oil raises over time, that increases the power of the model . And that lifts the equilibrium price very considerably to $97 a barrel, which is $30 a barrel higher than it currently is. So I regard that as my medium-term model, and the first one is my short-term model.

What’s really interesting is that the U.S. dollar  has continued to fall.  That puts further upward pressure  on the oil price. So in spite of this crisis having been solved, I think we’re going to see more upward price action on the oil price by the end of the year.

Read more